Very severe COVID-19 in the critically ill in Tunisia

Pan Afr Med J. 2020 Aug 6;35(Suppl 2):136. doi: 10.11604/pamj.supp.2020.35.136.24753. eCollection 2020.

Abstract

Introduction: SARS-CoV-2 is an emerging health threat outbreak. It may cause severe viral pneumonia with Acute Respiratory Distress Syndrome requiring critical care. Aim: to describe clinical features and outcomes of critically ill patients with SARS-CoV-2 infection.

Methods: it was a retrospective study carried out in the medical ICU of Farhat Hached teaching hospital between March 11 and May 7, 2020. All consecutive patients with RT-PCR confirmed COVID-19 were included. Clinical characteristics and outcomes were collected by reviewing medical records.

Results: during the study period, 10 critically ill patients with COVID-19 were enrolled. Mean age, 51.8±6.3 years; 8(80%), male. The most common comorbidities were; diabetes mellitus, 6(60%), obesity 2(20%), chronic kidney disease 2(20%) and hypertension 1(10%). Mean SAPS II, 23.2±1.8. The mean arterial oxygen partial pressure to fractional inspired oxygen ratio at admission was 136.2±79.7. Noninvasive mechanical ventilation was used in 4(40%) patients and 7(70%) received invasive mechanical ventilation. Tidal volume and PEEP were set respectively within the median [IQR] of, 5.7[5.6-6.3]ml/Kg and 10.7[6.5-11.7]cm H2O. Plateau pressure was monitored in the median [IQR] of 27.9 [25.9-28.5] cm H2O. Four patients received hydroxychloroquine alone and five hydroxychloroquine associated with an antiviral. Five patients developed respectively hyperactive (n=2), hypoactive (n=2) and mixed delirium (n=1). Mortality rate was at 70%.

Conclusion: this study demonstrated a particular profile of COVID-19 in the critically ill as a severe presentation in aged males with comorbidities presenting with an ARDS-like and neurological impairment with poor prognosis. The only survivals seem to have benefited from noninvasive ventilatory support.

Keywords: COVID-19; SARS-CoV-2; acute respiratory distress syndrome; pneumonia.

MeSH terms

  • Antiviral Agents / therapeutic use
  • Betacoronavirus*
  • COVID-19
  • COVID-19 Drug Treatment
  • Cardiovascular Diseases / epidemiology
  • Comorbidity
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology*
  • Critical Illness / epidemiology*
  • Delirium / etiology
  • Diabetes Mellitus / epidemiology
  • Female
  • Hospital Mortality
  • Hospitals, Teaching / statistics & numerical data
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Male
  • Middle Aged
  • Obesity / epidemiology
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / epidemiology*
  • Prognosis
  • Renal Insufficiency, Chronic / epidemiology
  • Respiration, Artificial / statistics & numerical data
  • Respiratory Distress Syndrome / etiology
  • Retrospective Studies
  • SARS-CoV-2
  • Simplified Acute Physiology Score
  • Tunisia / epidemiology

Substances

  • Antiviral Agents
  • Hydroxychloroquine